@article{11139,
  keywords = {Humans, *Sodium-Glucose Transporter 2 Inhibitors/therapeutic use/adverse effects, *Diabetes Mellitus, Type 2/drug therapy, Male, Female, *Glucagon-Like Peptide-1 Receptor/agonists, *Cardiovascular Diseases/prevention & control/epidemiology/mortality, Middle Aged, Aged, *Drug Therapy, Combination, Incidence, *Hypoglycemic Agents/therapeutic use/adverse effects, United Kingdom/epidemiology, Cohort Studies, Glucagon-like peptide-1 receptor agonists},
  author = {N. Simms-Williams and N. Treves and H. Yin and S. Lu and O. Yu and R. Pradhan and C. Renoux and S. Suissa and L. Azoulay},
  title = {Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study},
  year = {2024},
  journal = {Bmj},
  volume = {385},
  edition = {2024/04/26},
  pages = {e078242},
  isbn = {0959-8138 (Print)
0959-8138},
  doi = {10.1136/bmj-2023-078242},
  note = {1756-1833
Simms-Williams, Nikita
Treves, Nir
Yin, Hui
Lu, Sally
Yu, Oriana
Pradhan, Richeek
Renoux, Christel
Suissa, Samy
Azoulay, Laurent
Orcid: 0000-0001-5162-3556
Journal Article
Research Support, Non-U.S. Gov't
England
BMJ. 2024 Apr 25;385:e078242. doi: 10.1136/bmj-2023-078242.},
  language = {eng},
}